Detalles de la búsqueda
1.
Is radiotherapy after radical prostatectomy associated with higher other-cause mortality?
Cancer Causes Control;
34(12): 1139-1144, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37522983
2.
Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review.
BMC Cancer;
23(1): 398, 2023 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142955
3.
Quality of early prostate cancer follow-up care from the patients' perspective.
Support Care Cancer;
30(12): 10077-10087, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303075
4.
Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer.
Eur J Nucl Med Mol Imaging;
48(4): 1211-1218, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33025093
5.
Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions.
J Magn Reson Imaging;
51(4): 1235-1246, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31588646
6.
Management of the penile squamous cell carcinoma patient after node positive radical inguinal lymph node dissection: current evidence and future prospects.
Curr Opin Urol;
30(2): 223-228, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31895078
7.
Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients.
Magn Reson Med;
81(5): 3358-3369, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30656738
8.
Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer.
J Urol;
201(3): 478-485, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30321552
9.
Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.
J Magn Reson Imaging;
50(1): 269-278, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30585368
10.
Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy.
Eur Radiol;
29(8): 4160-4168, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30421016
11.
Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems.
Magn Reson Med;
79(3): 1586-1594, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28671331
12.
Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
NMR Biomed;
31(9): e3946, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29974981
13.
Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
Eur J Nucl Med Mol Imaging;
44(13): 2213-2226, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28780722
14.
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Lancet Oncol;
17(4): 464-474, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968359
15.
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol;
17(8): 1061-1069, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339116
16.
Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results From the Randomized Phase III HYPRO Trial.
J Sex Med;
13(11): 1695-1703, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27665195
17.
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Lancet Oncol;
16(3): 274-83, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25656287
18.
Erratum to: Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients (Magn Reson Med. 2019; 81: 3358-3369).
Magn Reson Med;
2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33349974
19.
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study.
Clin Transl Radiat Oncol;
46: 100742, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38440792
20.
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability.
Int J Radiat Oncol Biol Phys;
118(2): 378-389, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633499